Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 2,390 shares at $14.23 ($34K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Seasonal sale ($34k) by Chief Scientific Officer — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |
| ENTA | SELL | 2019-02-13 | $6.1M | — | Filing → |